Label: TERCONAZOLE suppository

  • NDC Code(s): 45802-717-00, 45802-717-08
  • Packager: Padagis Israel Pharmaceuticals Ltd
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated September 30, 2024

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION
    Rx Only
  • DESCRIPTION
    Terconazole Vaginal Suppositories, 80 mg are white to off-white suppositories for intravaginal administration containing 80 mg of the antifungal agent terconazole ...
  • CLINICAL PHARMACOLOGY
    Absorption - Following a single intravaginal application of a suppository containing 240 mg 14C-terconazole to healthy women, approximately 70% (range: 64-76%) of terconazole remains in the ...
  • INDICATIONS AND USAGE
    Terconazole Vaginal Suppositories, 80 mg are indicated for the local treatment of vulvovaginal candidiasis (moniliasis). As this product is effective only for vulvovaginitis caused by the genus ...
  • CONTRAINDICATIONS
    Patients known to be hypersensitive to terconazole or to any of the components of the suppositories.
  • WARNINGS
    Anaphylaxis and toxic epidermal necrolysis have been reported during terconazole therapy. Terconazole Vaginal Suppositories, 80 mg therapy should be discontinued if anaphylaxis or toxic epidermal ...
  • PRECAUTIONS
    General - For vulvovaginal use only. Terconazole Vaginal Suppositories, 80 mg is not for ophthalmic or oral use. Discontinue use and do not retreat with terconazole if sensitization ...
  • ADVERSE REACTIONS
    Adverse Reactions from Clinical Trials - Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly ...
  • OVERDOSAGE
    In the rat, the oral LD 50 values were found to be 1741 and 849 mg/kg for the male and female, respectively. The oral LD 50 values for the male and female dog were ≅1280 and ≥640 mg/kg ...
  • DOSAGE AND ADMINISTRATION
    One Terconazole Vaginal Suppository, 80 mg should be administered intravaginally once daily at bedtime for three consecutive days. Before prescribing another course of therapy, the diagnosis ...
  • HOW SUPPLIED
    Terconazole Vaginal Suppositories, 80 mg are available as follows: Carton containing 3 suppositories (NDC 45802-717-08)
  • STORAGE
    Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].
  • SPL UNCLASSIFIED SECTION
    Manufactured for Padagis® Minneapolis, MN 55427 - www.padagis.com - Rev 09-24 - 2X300 RC J13
  • Patient Instructions
    Terconazole Vaginal Suppositories, 80 mg - Three oval suppositories, for use inside the vagina only. Designed to be inserted into the vagina. HOW TO USE: Place one suppository into the vagina ...
  • Package/Label Display Panel
    Rx Only - Terconazole Vaginal Suppositories, 80 mg - 3 SUPPOSITORIES with vaginal applicator
  • INGREDIENTS AND APPEARANCE
    Product Information